~~<i id='E7DF60D9DB'><strike id='E7DF60D9DB'><tt id='E7DF60D9DB'><pre id='E7DF60D9DB'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

hotspot

author：focus 2025-10-01 22:59:11 - browse：449

Editor’s note: A livestream of the event is embedded below.

Enough talk about fairness, safety, and effectiveness. If we want AI systems to possess these attributes in health care, we have to test them with those goals in mind.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Analysis of telehealth claims data suggest service duplication

focus

hotspot

explore

focus

leisure time

knowledge

Theterm“exciteddelirium”hasbeenusedforyearsbylawenforcementandotherfirstresponders,includinghealthca

WSS

Senate panel eyes new effort on drug shortages

FDA rejects Alnylam's heart disease treatment over insufficient data

When women are denied an abortion, their children fare worse than peers

White House calls on federal agencies to crack down on AI abuses

Abortion clinic in Cancun will cater to Americans

Study: New antibiotic targets gonorrhea as well as last existing drug

focus

hotspot

focus

Hollywood unions extend contract negotiations for actors

Abortion clinic in Cancun will cater to Americans

Activists slam private health insurers over coverage restrictions

Medicare solvency divides Republicans at the presidential debate

Moonlake's readout produced a cash windfall. Risks remain

Chemotherapy drug shortage eases slightly but still widespread

Moonlake's readout produced a cash windfall. Risks remain

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

In Memoriam: Notable people who died in 2023

hotspot

Histogen: Failed biotech offers rare public look inside

Biotech incubator Curie.Bio graduates its first startup

Free speech concerns arise in wake of journal editor Eisen's firing

Was Amgen transparent enough on FDA's concern on cancer drug?

When women are denied an abortion, their children fare worse than peers

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

explore

focus

leisure time

knowledge